CME Science PET On-Demand 2024

Regular price
$110.00
Sale price
$110.00
Regular price
$0
Sold out
Unit price
Quantity must be 1 or more

CME Science PET On-Demand 2024

Format: 16 videos: 3.32 GB

Course Audience: practicing radiologists, nuclear medicine physicians

Overview:

Educational Objectives

This course provides a clinical perspective of PET/CT imaging and the emerging use of Theranostic agents within Nuclear Medicine. A broad perspective on the economic, clinical, and academic aspects of the latest trends in PET/CT imaging and Nuclear Medicine therapy will be presented.

At the conclusion of this course, participants will be able to:

Describe new developments in the merger of diagnostic and therapeutic radioligands for PET/CT imaging and therapy with specific focus on DOTA, PSMA, and PRRT

Describe the logistis of bringing these new diagnostic and therapeutic technologies to clinical practice

Identify the key clinical indications for new emerging tracers for Neuroendocrine Tumor and Prostate cancer using somatostatin receptor and PSMA PET/CT imaging

Review and discuss the standard-of-care clinical application and advanced interpretation of FDG PET/CT

With the recent approval by CMS Medicare for DOTATATE (NETSPOT) PET/CT and the rapid international adoption of targeted Lu-177 based therapies for neuroendocrine and prostate cancers, it is clear that Nuclear Medicine and PET/CT are entering into a new era. New diagnostic and therapeutic agents with remarkable sensitivity and specificity are revolutionizing Nuclear Medicine and Oncology. This course will highlight the latest targeted imaging agents for neuroendocrine and prostate cancers (Ga-68 DOTATATE and Ga-68 PSMA PET/CT) as well as review important core concepts in PET/CT imaging and therapeutic Nuclear Medicine.

Target Audience

This course is intended for practicing radiologists, nuclear medicine physicians and radiologic nurses, physician assistants, technologists, residents, fellows and others who are interested in the clinical applications of PET and PET/CT.

Release date: 12/14/2023

01 – Introduction to Theranostics (Video MP4 Format)

02 – Challenging and Instructive Abdomen and Pelvis (Video MP4 Format)

03 – Important of Patient Preparation for PET,CT (Video MP4 Format)

04 – PET,CT in Head and Neck Cancer (Video MP4 Format)

05 – Update on Radioiodine Treatment for Thyroid Cancer (Video MP4 Format)

06 – Nuclear Medicine and Benign Thyroid Disease (Video MP4 Format)

07 – Challenging and Interactive Chest PET,CT (Video MP4 Format)

08 – Neuroendocrine Tumor Imaging with DOTA PET,CT (Video MP4 Format)

09 – Update on Nuclear Medicine for Infection and Inflammation (Video MP4 Format)

10 – Lu-177 PSMA Therapy Lessons from the Vision Trial (Video MP4 Format)

11 – General Nuclear Medicine in 60 Minutes (Video MP4 Format)

12 – PET Imaging for the Differential Diagnosis of Dementia (Video MP4 Format)

13 – Dopamine Transporter Imaging of Parkinsonian Syndromes (Video MP4 Format)

14 – Somatostatin Radiotherapy – Our New Era of Nuclear Medicine (Video MP4 Format)

15 – Prostate Cancer PET Imaging (Video MP4 Format)

16 – Neurotheranostics – Next Frontier for Health Span (Video MP4 Format)

Go to full site